Digital Biomarkers in Neurology: Early Diagnosis and Disease Management

Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment. In the face of such complexity, emerging digital biomarkers, powered by advanced technology and comprehensive data analytics, offer great promise. They unlock a novel pathway to insights, facilitating not just early detection but also more adept management of neurological conditions. By harnessing data from devices and specific sensors, digital biomarkers are paving the way towards precision diagnostics and tailor-made therapeutic strategies.

If you are interested in the potential of digital biomarkers in neurology, and learning how to harness them effectively, join this roundtable discussion which will cover:

• Harnessing Digital Biomarkers for Neurology: How can we best identify and use digital biomarkers for the early detection of neurological disorders? Which conditions hold the most potential, and what biomarkers are most suitable?  

• Validation of Digital Biomarkers: Which digital biomarkers have already demonstrated their efficacy in neurology, and what regulatory guidelines and considerations are required? 

• Limitations of Current Digital Biomarkers: What practical applications and limitations exist for neurological biomarkers, and how to overcome these challenges? 

• Future of Digital Biomarkers in Neurology: What groundwork is required for these digital biomarkers to become standard tools for neurologists?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day